Nikko Asset Management Americas, Inc. Castle Biosciences Inc Transaction History

Nikko Asset Management Americas, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$16.0 - $45.99 $251,184 - $721,997	15,699 Added 3.67%	443,882 $9.57 Million
Q1 2022 May 06, 2022	SELL	$33.17 - $46.98 $3.5 Million - $4.96 Million	-105,494 Reduced 19.77%	428,183 $16.7 Million
Q4 2021 Feb 08, 2022	BUY	$39.06 - $67.58 $224,790 - $388,922	5,755 Added 1.09%	533,677 $21.9 Million
Q3 2021 Nov 09, 2021	BUY	$60.13 - $77.6 $4.98 Million - $6.43 Million	82,810 Added 18.6%	527,922 $26.4 Million
Q2 2021 Aug 09, 2021	BUY	$50.07 - $76.78 $22.3 Million - $34.2 Million	445,112 New	445,112 $28.4 Million

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $701M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.